SHANGHAI, April 29, 2026 /PRNewswire/ -- United Imaging Healthcare (688271.SH)，a global innovator in advanced medical imaging technologies and intelligent healthcare solutions, announced its 2025 annual results and Q1 2026 performance, both delivering solid growth. In 2025, the company reported revenue of RMB 13.80 billion, representing a year-on-year increase of 33.98%, and net profit attributable to shareholders of RMB 1.87 billion, up 48.14% year-on-year. In Q1 2026, the company maintained steady growth momentum, reporting revenue of RMB 2.91 billion, a year-on-year increase of 17.34%, and net profit attributable to shareholders of RMB 0.40 billion, representing a 7.78% year-on-year increase.

In 2025, United Imaging Healthcare continued to deepen its commitment to innovation, with annual R&D investment reaching RMB 2.62 billion, up 15.95% year-on-year. Leveraging sustained high-intensity R&D investment and its globally coordinated innovation network, the Company made significant progress in core underlying technologies, key component breakthroughs, and system integration capabilities, with multiple strategic products successfully commercialized. A key outcome was the launch of the uSONIQUE ultrasound series, which completed the company's imaging portfolio and solidified its position as a total-solution provider for the global market.

As of the end ...